The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0.
Ogle WO, Ng TI, Carter KL, Roizman B.
Ogle WO, et al. Among authors: roizman b.
Virology. 1997 Sep 1;235(2):406-13. doi: 10.1006/viro.1997.8710.
Virology. 1997.
PMID: 9281521
Free article.
Thus, ICP22 regulates both the utilization of splice acceptor sites and the longevity of ICP0 mRNA (K. L. Carter and B. Roizman, 1996, Proc. Natl. Acad. Sci. USA 93, 12535-12540); UL13 is involved in the posttranslational modification of ICP0 and is required for bot …
Thus, ICP22 regulates both the utilization of splice acceptor sites and the longevity of ICP0 mRNA (K. L. Carter and B. Roizman …